HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael Burt Manjit S. Bains Nael Martini Patricia M. McCormack Valerie W. Rusch Robert J. Ginsberg Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burt, M. Articles by Ginsberg, R. J. Search for Related Content PubMed PubMed Citation Articles by Burt, M. Articles by Ginsberg, R. J.

Ann Thorac Surg 1992;54:226-232
© 1992 The Society of Thoracic Surgeons

---

Articles

Primary bony and cartilaginous sarcomas of chest wall: Results of therapy

Thoracic Service, Department of Surgery, and Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York USA

^_* Address reprint requests to Dr Burt, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021.

Primary bony and cartilaginous sarcomas of the chest wall are uncommon, and data concerning treatment and results are sparse. To assess the results of therapy, we reviewed our 40-year experience. Records of 38 patients with osteosarcoma and 88 with chondrosarcoma arising in chest wall admitted to Memorial Sloan-Kettering Cancer Center from 1949 to 1989 were reviewed. The 88 patients with chondrosarcoma ranged in age from 5 to 86 years (median age, 49 years); the male/female ratio was 1.3:1. Presenting complaint was mass, pain, or both in 93%. Primary therapy was resection (n = 84), radiation therapy (n = 3), or chemotherapy (n = 1). Overall 5-year survival was 64%. Significant adverse prognostic factors included metastases at initial presentation (n = 9), metastases at any time during the course of disease (n = 23), age greater than 50 years (n = 42), incomplete or no resection (n = 13), and local recurrence (n = 24). Sex, grade, and tumor size were not prognostic factors. The 38 patients with osteosarcoma ranged in age from 11 to 78 years (median age, 42 years); the male/female ratio was 1.5:1. Presenting complaint was mass, pain, or both in 95%. Primary therapy included resection (n = 31; alone in 13, with radiation therapy in 3, with chemotherapy in 15), radiation therapy (n = 3), radiation therapy and chemotherapy (n = 2), chemotherapy (n = 1), or no treatment (n = 1). Overall 5-year survival was 15%. Significant adverse prognostic factors included presence of synchronous metastases (n = 13) and metastases at any time during the course of disease (n = 26). Age, sex, tumor size, local recurrence, and extent of resection were not prognostic factors. In conclusion, patients with chest wall osteosarcoma have a significantly decreased 5-year survival (15%) compared with those with chondrosarcoma (64%). Resection allows acceptable survival for patients with chondrosarcoma, but the role of adjuvant therapy should continue to be explored in patients with osteosarcoma of chest wall.

This article has been cited by other articles:

				B. Widhe and H. C.F. Bauer Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 610 - 614. [Abstract] [Full Text] [PDF]

				M. W. Wouters, A. N. van Geel, L. Nieuwenhuis, H. van Tinteren, C. Verhoef, F. van Coevorden, and H. M. Klomp Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas J. Clin. Oncol., November 1, 2008; 26(31): 5113 - 5118. [Abstract] [Full Text] [PDF]

				A. R. Chapelier, M.-C. Missana, B. Couturaud, E. Fadel, D. Fabre, S. Mussot, P. Pouillart, and P. G. Dartevelle Sternal resection and reconstruction for primary malignant tumors Ann. Thorac. Surg., March 1, 2004; 77(3): 1001 - 1007. [Abstract] [Full Text] [PDF]

				K. Athanassiadi, G. Kalavrouziotis, D. Rondogianni, A. Loutsidis, A. Hatzimichalis, and I. Bellenis Primary chest wall tumors: early and long-term results of surgical treatment Eur J Cardiothorac Surg, May 1, 2001; 19(5): 589 - 593. [Abstract] [Full Text] [PDF]

				G. L. Walsh, B. M. Davis, S. G. Swisher, A. A. Vaporciyan, W. R. Smythe, K. Willis-Merriman, J. A. Roth, and J. B. Putnam Jr A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0048 - 60. [Abstract] [Full Text] [PDF]

				S. K. Chowdhury, K. S. V. K. Subbarao, M. Nachiappan, K. Agrawal, S. K. Chowdhury, K. S. V. K. Subbarao, M. Nachiappan, and K. Agrawal Primary Neoplasm of the Chest Wall: Surgical Management Asian Cardiovasc Thorac Ann, September 1, 2000; 8(3): 249 - 252. [Abstract] [Full Text] [PDF]

				P. Noirhomme, Y. d'Udekem, E. Munting, G. El Khoury, Y. Humblet, and R. A. Dion Resection of a Chest Chondrosarcoma Invading the Spine and the Aorta Ann. Thorac. Surg., February 1, 1998; 65(2): 534 - 534. [Abstract] [Full Text] [PDF]

				N. Martini, A. G. Huvos, M. E. Burt, R. T. Heelan, M. S. Bains, P. M. McCormack, V. W. Rusch, M. Weber, R. J. Downey, and R. J. Ginsberg PREDICTORS OF SURVIVAL IN MALIGNANT TUMORS OF THE STERNUM J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 96 - 106. [Abstract] [Full Text]

				B. O. Anderson and M. E. Burt Chest wall neoplasms and their management Ann. Thorac. Surg., December 1, 1994; 58(6): 1774 - 1781. [Abstract] [PDF]